• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多囊卵巢综合征女性的心脏代谢生物标志物。

Cardiometabolic biomarkers in women with polycystic ovary syndrome.

机构信息

Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Erasmus University Medical Center, Rotterdam, Netherlands.

Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Erasmus University Medical Center, Rotterdam, Netherlands.

出版信息

Fertil Steril. 2022 May;117(5):887-896. doi: 10.1016/j.fertnstert.2022.03.008.

DOI:10.1016/j.fertnstert.2022.03.008
PMID:35512973
Abstract

Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in women of reproductive age. Apart from the reproductive problems, PCOS is also associated with metabolic disturbances, and therefore, it also affects adolescents and postmenopausal women with PCOS as well as their offspring and other first-degree relatives. Adolescents with PCOS show unfavorable cardiometabolic biomarkers more often than controls, such as overweight/obesity and hyperandrogenism, and studies also suggest an unfavorable lipid profile. During reproductive age, women with PCOS develop additional cardiometabolic biomarkers, such as hypertension, insulin resistance, and metabolic syndrome. Growing evidence also supports the important role of inflammatory cytokines in cardiovascular health in these women. During menopausal transition, some PCOS characteristics ameliorate, whereas other biomarkers increase, such as body mass index, insulin resistance, type 2 diabetes, and hypertension. Offspring of women with PCOS have a lower birth weight and a higher body mass index later in life than controls. In addition, fathers, mothers, and siblings of women with PCOS show unfavorable cardiometabolic biomarkers. Therefore, cardiovascular screening and follow-up of women with PCOS and their offspring and siblings are of utmost importance.

摘要

多囊卵巢综合征(PCOS)是育龄妇女最常见的内分泌疾病。除了生殖问题外,PCOS 还与代谢紊乱有关,因此,它也会影响患有 PCOS 的青少年和绝经后妇女及其后代和其他一级亲属。患有 PCOS 的青少年比对照组更常出现不利的心血管代谢生物标志物,如超重/肥胖和高雄激素血症,研究还表明血脂状况不佳。在生育年龄,患有 PCOS 的妇女会出现其他心血管代谢生物标志物,如高血压、胰岛素抵抗和代谢综合征。越来越多的证据也支持炎症细胞因子在这些妇女心血管健康中的重要作用。在绝经过渡期间,一些 PCOS 特征会改善,而其他生物标志物会增加,如体重指数、胰岛素抵抗、2 型糖尿病和高血压。患有 PCOS 的妇女的后代出生体重较低,成年后体重指数较高。此外,患有 PCOS 的妇女的父亲、母亲和兄弟姐妹表现出不利的心血管代谢生物标志物。因此,对患有 PCOS 的妇女及其后代和兄弟姐妹进行心血管筛查和随访非常重要。

相似文献

1
Cardiometabolic biomarkers in women with polycystic ovary syndrome.多囊卵巢综合征女性的心脏代谢生物标志物。
Fertil Steril. 2022 May;117(5):887-896. doi: 10.1016/j.fertnstert.2022.03.008.
2
Cardiometabolic Risk, Peripheral Arterial Disease and Cardiovascular Events in Polycystic Ovary Syndrome: Time to Implement Systematic Screening and Update the Management.多囊卵巢综合征中的心脏代谢风险、外周动脉疾病和心血管事件:是时候实施系统筛查和更新管理了。
Curr Vasc Pharmacol. 2023;21(6):424-432. doi: 10.2174/0115701611269146230920073301.
3
Subclinical cardiovascular disease and polycystic ovary syndrome.亚临床心血管疾病与多囊卵巢综合征。
Fertil Steril. 2022 May;117(5):912-923. doi: 10.1016/j.fertnstert.2022.02.028.
4
Cardiovascular disease risk in offspring of polycystic ovary syndrome.多囊卵巢综合征患者后代的心血管疾病风险。
Front Endocrinol (Lausanne). 2022 Nov 30;13:977819. doi: 10.3389/fendo.2022.977819. eCollection 2022.
5
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME - PART 2.美国临床内分泌医师协会、美国内分泌学会以及雄激素过多与多囊卵巢综合征协会疾病状态临床综述:多囊卵巢综合征评估与治疗最佳实践指南 - 第2部分。
Endocr Pract. 2015 Dec;21(12):1415-26. doi: 10.4158/EP15748.DSCPT2.
6
Polycystic ovarian syndrome.多囊卵巢综合征
J Cardiometab Syndr. 2006 Spring;1(2):125-30; quiz 131-2. doi: 10.1111/j.1559-4564.2006.05675.x.
7
Heart health in polycystic ovary syndrome: time to act on the data.多囊卵巢综合征的心脏健康:是时候对数据采取行动了。
Fertil Steril. 2022 May;117(5):885-886. doi: 10.1016/j.fertnstert.2022.03.014.
8
Polycystic ovary syndrome: a "risk-enhancing" factor for cardiovascular disease.多囊卵巢综合征:心血管疾病的“风险增强”因素。
Fertil Steril. 2022 May;117(5):924-935. doi: 10.1016/j.fertnstert.2022.03.009.
9
Menstrual disorders in adolescence: a marker for hyperandrogenaemia and increased metabolic risks in later life? Finnish general population-based birth cohort study.青春期月经紊乱:成年后高雄激素血症和代谢风险增加的标志物?芬兰基于一般人群的出生队列研究。
Hum Reprod. 2012 Nov;27(11):3279-86. doi: 10.1093/humrep/des309. Epub 2012 Aug 29.
10
Changes in the PCOS phenotype with age.多囊卵巢综合征表型随年龄的变化。
Steroids. 2013 Aug;78(8):761-6. doi: 10.1016/j.steroids.2013.04.005. Epub 2013 Apr 25.

引用本文的文献

1
The Molecular Basis of Polycystic Ovary Syndrome and Its Cardiometabolic Correlates: Exploring the Intersection and Its Clinical Implications-A Narrative Review.多囊卵巢综合征的分子基础及其心脏代谢相关性:探索交叉点及其临床意义——一篇叙述性综述
Biomedicines. 2025 Mar 13;13(3):709. doi: 10.3390/biomedicines13030709.
2
Insulin Resistance in an Underweight Woman with Polycystic Ovary Syndrome: A Case Study.一名体重过轻的多囊卵巢综合征女性的胰岛素抵抗:病例研究
Am J Case Rep. 2025 Feb 3;26:e945814. doi: 10.12659/AJCR.945814.
3
Screening of serum biomarkers in patients with PCOS through lipid omics and ensemble machine learning.
通过脂质组学和集成机器学习对多囊卵巢综合征患者的血清生物标志物进行筛查。
PLoS One. 2025 Jan 7;20(1):e0313494. doi: 10.1371/journal.pone.0313494. eCollection 2025.
4
Serum adiponectin level is negatively related to insulin resistance in women with polycystic ovary syndrome.多囊卵巢综合征女性的血清脂联素水平与胰岛素抵抗呈负相关。
Endocr Connect. 2024 Dec 13;14(1). doi: 10.1530/EC-24-0401. Print 2025 Jan 1.
5
Increased Vasoactive Intestinal Peptide (VIP) in polycystic ovary syndrome patients undergoing IVF.多囊卵巢综合征患者在行体外受精(IVF)中血管活性肠肽(VIP)增加。
Front Endocrinol (Lausanne). 2024 May 7;15:1331282. doi: 10.3389/fendo.2024.1331282. eCollection 2024.
6
Association of severity of menstrual dysfunction with cardiometabolic risk markers among women with polycystic ovary syndrome.多囊卵巢综合征女性的月经功能障碍严重程度与心血管代谢风险标志物的相关性。
Acta Obstet Gynecol Scand. 2024 Aug;103(8):1606-1614. doi: 10.1111/aogs.14863. Epub 2024 May 7.
7
Associations of Polycystic Ovary Syndrome With Indicators of Brain Health at Midlife in the CARDIA Cohort.多囊卵巢综合征与 CARDIA 队列中年中大脑健康指标的关联。
Neurology. 2024 Feb 27;102(4):e208104. doi: 10.1212/WNL.0000000000208104. Epub 2024 Jan 31.
8
Association of Fat Mass and Skeletal Muscle Mass with Cardiometabolic Risk Varied in Distinct PCOS Subtypes: A Propensity Score-Matched Case-Control Study.不同多囊卵巢综合征亚型中体脂和骨骼肌质量与心血管代谢风险的关联各异:一项倾向评分匹配的病例对照研究
J Clin Med. 2024 Jan 15;13(2):483. doi: 10.3390/jcm13020483.
9
Risk of cardiocerebrovascular diseases is increased in Korean women with polycystic ovary syndrome: a nationwide cohort study.多囊卵巢综合征韩国女性患心脑血管疾病的风险增加:一项全国性队列研究。
Sci Rep. 2024 Jan 11;14(1):1055. doi: 10.1038/s41598-023-50650-y.
10
Polycystic Ovarian Syndrome: a Risk Factor for Cardiovascular Disease.多囊卵巢综合征:心血管疾病的一个风险因素。
Curr Atheroscler Rep. 2023 Dec;25(12):1003-1011. doi: 10.1007/s11883-023-01168-1. Epub 2023 Dec 4.